14 Best Biotech Stocks To Buy According To Hedge Funds
Biotechnology is one of the hottest sectors these days. A handful of industries, such as space exploration, artificial intelligence, and biotechnology, are making rapid leaps forward.
United Therapeutics Corp (UTHR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 2,870,000 | $642,765,200 | +1% | 9.52% |
| 2. | Farallon Capital Thomas Steyer | 664,767 | $148,881,217 | +2% | 0.84% |
| 3. | Palo Alto Investors William Leland Edwards | 627,514 | $140,538,035 | +1% | 11.64% |
| 4. | AQR Capital Management Cliff Asness | 373,223 | $82,377,781 | +44% | 0.18% |
| 5. | Polar Capital Brian Ashford-Russell And Tim Woolley | 324,075 | $72,579,837 | -1% | 0.52% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.83 | 4 | Director | 1,684 | 2019-06-10 | Filing | |
| $114.06 | 6 | Director | 1,686 | 2018-04-20 | Filing | |
| $126.20 | 5 | Director | 1,685 | 2017-11-20 | Filing | |
| $128.35 | 3 | Director | 1,686 | 2017-07-28 | Filing | |
| $130.24 | 3 | Director | 1,683 | 2017-07-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $209.72 | 2,850 | 36,599 | 2023-06-01 | Filing | ||
| $208.79 | 2,750 | 39,449 | 2023-06-01 | Filing | ||
| $207.01 | 400 | 42,199 | 2023-06-01 | Filing | ||
| $214.89 | 3,006 | 36,599 | 2023-05-18 | Filing | ||
| $214.27 | 2,994 | 39,605 | 2023-05-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 4,751,961 | $1,064,249,185 | 0.03% | |
| 2. | 4,605,917 | $1,031,541,172 | 0.02% | |
| 3. | 3,781,840 | $846,980,886 | 0.16% | |
| 4. | 2,537,457 | $568,288,863 | 0.05% | |
| 5. | 1,795,102 | $402,031,044 | 0.02% |
News See All
Billionaire Jim Simons' 2023 Portfolio: Top 15 Stock Picks
Managed by Renaissance Technologies, the Medallion Fund stands as one of the world's most prosperous and enigmatic hedge funds.
United Therapeutics Corporation (NASDAQ:UTHR) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the United Therapeutics Corporation First Quarter 2023 Earnings Webcast. My name is Danielle, and I will be your conference operator today.
United Therapeutics Corporation (NASDAQ:UTHR) Q4 2022 Earnings Call Transcript
Operator: Good morning and welcome to the United Therapeutics Corporation Fourth Quarter and Full Year 2022 Earnings Webcast. My name is Devin, and I will be your conference operator today.
13 High Growth Pharma Stocks that are Profitable
One industry that has rapidly evolved with time and impacted millions, if not billions, of lives is the pharmaceutical sector.
12 Cheap Biotech Stocks To Buy
Some of the more famous names in the biotech space include companies like Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), BioNTech SE (NASDAQ:BNTX), and AbbVie Inc. (NYSE:ABBV).
10 Best Healthcare Stocks For Recession
The healthcare sector in 2022 outperformed the market despite several headwinds and a negative macroeconomic backdrop.
Hedge Fund and Insider Trading News: Cathie Wood, Steve Cohen, AQR Capital Management, Brevan Howard Asset Management, Three Arrows Capital, Impactive Capital, Alphabet Inc. (GOOG), and More
AQR Capital Management’s longest-running strategy had its best year since its inception in 1998, posting a gain of 43.5% net of fees, as a range of its funds achieved record performance.
Jim Simons Stock Portfolio: 5 Biggest Healthcare Stocks
Jim Simons’ RenTech scaled back the size of its Molina Healthcare, Inc. (NYSE:MOH) holding by 15% during Q3, leaving the quant fund with over 1.46 million shares entering the final quarter of 2022.
5 Best Biotech Stocks To Buy According To Hedge Funds
United Therapeutics Corporation (NASDAQ:UTHR) is a biotechnology company engaged in the development and commercialization of medical products and therapies to address the unmet needs of patients with ...
Billionaire Hedge Funds
